# PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia

> **NCT05919199** · — · UNKNOWN · sponsor: **First Affiliated Hospital of Jinan University** · enrollment: 60 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT05919199
- **Lead sponsor:** First Affiliated Hospital of Jinan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-03
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919199, "PET Tracer Based FDG Signal for Predicting Prognosis in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05919199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*